We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




AI Tool Rapidly Analyzes Complex Cancer Images for Personalized Treatment

By LabMedica International staff writers
Posted on 05 Dec 2025

Complex digital biopsy images that typically take an expert pathologist up to 20 minutes to assess can now be analyzed in about one minute using a new artificial intelligence (AI) tool. More...

The technology can detect cancer, identify where tumor lesions are located, and estimate the proportions of regions with varying aggressiveness. It offers a faster, more informative way to interpret tissue samples and could support more personalized treatment decisions.

The AI model, developed by researchers at the University of Cambridge (Cambridge, England, UK), was trained only on slides labeled with basic diagnostic information rather than detailed annotations. Using Superpatch-based Measurable Multiple Instance Learning, the system analyzes whole-slide images to map cancer subtypes and grade distributions, even though it was trained without region-level guidance. By capturing the heterogeneous composition of tumors, the algorithm mimics how clinicians interpret complex tissue structures.

To evaluate performance, the team tested the model on eight datasets containing 3,850 whole-slide images representing lung, kidney, ovarian, breast, stomach, and prostate cancers. The study, published in Nature Cancer, showed that the tool delivered slide-level classification accuracy comparable to or better than nine leading AI systems. It also dramatically outperformed them in estimating tumor subtype proportions and spatial distribution across tissues.

These findings suggest that the tool could streamline diagnostic workflows and expand access to advanced cancer profiling. Because it trains on inexpensive, widely available datasets, it may help overcome cost barriers associated with spatial tumor mapping. The team now plans to apply the system to predict molecular biomarkers, providing deeper insights into tumor biology and enabling more tailored treatment strategies.

“By allowing pathologists to make faster, more accurate diagnoses, we can make sure patients receive the best treatment even sooner, improving our chances of successfully treating their cancer,” said Dr. Zeyu Gao, Early Cancer Institute, University of Cambridge, developer of the algorithm.

Related Links:
University of Cambridge


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Connectivity Solution
EKF Link
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.